MedTrace Logo

Autologous Platelet Enriched Gel Versus Metalloproteinase Inhibitor in the Healing of Chronic Lower Leg Ulcers

NCT00658983 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2023-01-05

No results posted yet for this study

Summary

Compare Autologous Platelet Enriched Gel versus Metalloproteinase Inhibitor in the healing of chronic lower leg ulcers.

Conditions

  • Chronic Lower Leg Ulcer

Interventions

OTHER

Autologous Platelet Enriched Gel

Treatment with Autologous Platelet Enriched Gel

OTHER

Metalloproteinase Inhibitor

Treatment with Metalloproteinase Inhibitor (Promogran)

Sponsors & Collaborators

Principal Investigators

  • Wim Bongaerts, MD · University Hospital, Ghent

  • Wouter De Moor · University Hospital, Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-01
Primary Completion
2010-08-20
Completion
2010-08-20

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00658983 on ClinicalTrials.gov